A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

A spokeswoman for Mr. Kennedy declined to comment. The first of many lawsuits claiming that young people were harmed by the HPV vaccine is on trial in Los Angeles Superior Court. Mr. Kennedy has ...

2:08 Island Health to offer HPV vaccine to high school students Nurses on Vancouver Island will be heading to schools soon to offer a vaccine to grade 11 and 12 students. They will be offering the ...

In 2006, a vaccine for the human papillomavirus (HPV) became widely available to adolescents. HPV is the most common sexually transmitted infection, and it can cause cancers of the mouth, throat, and ...

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18.

To minimize the threats caused by the virus, the DOH recommended HPV vaccines be administered to girls as young as nine years old. “So bago pa siya maging sexually active, dapat nabibigay na. We ...

The human papillomavirus (HPV) vaccine plays a crucial role in the human body by preventing various types of cancers linked to HPV infection, particularly cervical cancer. HPV vaccine not only ...

Aizawl: Mizoram health & family welfare department will soon start administering Human Papilloma Virus (HPV) vaccination to girls between the age of 9 and 14, Dr Lalmuanawma Jongte, joint director ...

MANILA, Philippines — The health department is ready to roll out its planned human papillomavirus (HPV) vaccination program for all young girls in 2025, following President Ferdinand Marcos Jr ...

Young people are being urged to take up the HPV vaccine in schools when offered - a jab that can protect them against some cancers. According to the UK Health Security Agency (UKHSA), latest ...

Adar Poonawala led-Serum Institute of India (SII) is gearing up to include its newly launched HPV (human papillomavirus) vaccine targeted towards cervical cancer in India’s Universal ...

Parental fears on the safety of the vaccine; personal, cultural and religious reasons; and misinformation and disinformation have contributed to the low acceptance level.